Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical CDMO Solution Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Active Pharmaceutical Ingredient (API) Manufacturing
1.2.3 Finished Dosage Formulation (FDF) Development and Manufacturing
1.2.4 Secondary Packaging
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pharmaceutical CDMO Solution Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology Company
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical CDMO Solution Market Perspective (2018-2033)
2.2 Pharmaceutical CDMO Solution Growth Trends by Region
2.2.1 Global Pharmaceutical CDMO Solution Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Pharmaceutical CDMO Solution Historic Market Size by Region (2018-2023)
2.2.3 Pharmaceutical CDMO Solution Forecasted Market Size by Region (2024-2033)
2.3 Pharmaceutical CDMO Solution Market Dynamics
2.3.1 Pharmaceutical CDMO Solution Industry Trends
2.3.2 Pharmaceutical CDMO Solution Market Drivers
2.3.3 Pharmaceutical CDMO Solution Market Challenges
2.3.4 Pharmaceutical CDMO Solution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical CDMO Solution Players by Revenue
3.1.1 Global Top Pharmaceutical CDMO Solution Players by Revenue (2018-2023)
3.1.2 Global Pharmaceutical CDMO Solution Revenue Market Share by Players (2018-2023)
3.2 Global Pharmaceutical CDMO Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical CDMO Solution Revenue
3.4 Global Pharmaceutical CDMO Solution Market Concentration Ratio
3.4.1 Global Pharmaceutical CDMO Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical CDMO Solution Revenue in 2022
3.5 Pharmaceutical CDMO Solution Key Players Head office and Area Served
3.6 Key Players Pharmaceutical CDMO Solution Product Solution and Service
3.7 Date of Enter into Pharmaceutical CDMO Solution Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical CDMO Solution Breakdown Data by Type
4.1 Global Pharmaceutical CDMO Solution Historic Market Size by Type (2018-2023)
4.2 Global Pharmaceutical CDMO Solution Forecasted Market Size by Type (2024-2033)
5 Pharmaceutical CDMO Solution Breakdown Data by Application
5.1 Global Pharmaceutical CDMO Solution Historic Market Size by Application (2018-2023)
5.2 Global Pharmaceutical CDMO Solution Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Pharmaceutical CDMO Solution Market Size (2018-2033)
6.2 North America Pharmaceutical CDMO Solution Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Pharmaceutical CDMO Solution Market Size by Country (2018-2023)
6.4 North America Pharmaceutical CDMO Solution Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical CDMO Solution Market Size (2018-2033)
7.2 Europe Pharmaceutical CDMO Solution Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Pharmaceutical CDMO Solution Market Size by Country (2018-2023)
7.4 Europe Pharmaceutical CDMO Solution Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical CDMO Solution Market Size (2018-2033)
8.2 Asia-Pacific Pharmaceutical CDMO Solution Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Pharmaceutical CDMO Solution Market Size by Region (2018-2023)
8.4 Asia-Pacific Pharmaceutical CDMO Solution Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical CDMO Solution Market Size (2018-2033)
9.2 Latin America Pharmaceutical CDMO Solution Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Pharmaceutical CDMO Solution Market Size by Country (2018-2023)
9.4 Latin America Pharmaceutical CDMO Solution Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical CDMO Solution Market Size (2018-2033)
10.2 Middle East & Africa Pharmaceutical CDMO Solution Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Pharmaceutical CDMO Solution Market Size by Country (2018-2023)
10.4 Middle East & Africa Pharmaceutical CDMO Solution Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Recipharm AB
11.1.1 Recipharm AB Company Detail
11.1.2 Recipharm AB Business Overview
11.1.3 Recipharm AB Pharmaceutical CDMO Solution Introduction
11.1.4 Recipharm AB Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.1.5 Recipharm AB Recent Development
11.2 Lonza Group
11.2.1 Lonza Group Company Detail
11.2.2 Lonza Group Business Overview
11.2.3 Lonza Group Pharmaceutical CDMO Solution Introduction
11.2.4 Lonza Group Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.2.5 Lonza Group Recent Development
11.3 Catalent
11.3.1 Catalent Company Detail
11.3.2 Catalent Business Overview
11.3.3 Catalent Pharmaceutical CDMO Solution Introduction
11.3.4 Catalent Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.3.5 Catalent Recent Development
11.4 Patheon (Thermo Fisher Scientific)
11.4.1 Patheon (Thermo Fisher Scientific) Company Detail
11.4.2 Patheon (Thermo Fisher Scientific) Business Overview
11.4.3 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Introduction
11.4.4 Patheon (Thermo Fisher Scientific) Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.4.5 Patheon (Thermo Fisher Scientific) Recent Development
11.5 Siegfried AG
11.5.1 Siegfried AG Company Detail
11.5.2 Siegfried AG Business Overview
11.5.3 Siegfried AG Pharmaceutical CDMO Solution Introduction
11.5.4 Siegfried AG Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.5.5 Siegfried AG Recent Development
11.6 SGS Quay Pharmaceuticals
11.6.1 SGS Quay Pharmaceuticals Company Detail
11.6.2 SGS Quay Pharmaceuticals Business Overview
11.6.3 SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Introduction
11.6.4 SGS Quay Pharmaceuticals Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.6.5 SGS Quay Pharmaceuticals Recent Development
11.7 Curia
11.7.1 Curia Company Detail
11.7.2 Curia Business Overview
11.7.3 Curia Pharmaceutical CDMO Solution Introduction
11.7.4 Curia Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.7.5 Curia Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Detail
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Pharmaceutical CDMO Solution Introduction
11.8.4 Thermo Fisher Scientific Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 Samsung Biologics
11.9.1 Samsung Biologics Company Detail
11.9.2 Samsung Biologics Business Overview
11.9.3 Samsung Biologics Pharmaceutical CDMO Solution Introduction
11.9.4 Samsung Biologics Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.9.5 Samsung Biologics Recent Development
11.10 Fujifilm Diosynth Biotechnologies
11.10.1 Fujifilm Diosynth Biotechnologies Company Detail
11.10.2 Fujifilm Diosynth Biotechnologies Business Overview
11.10.3 Fujifilm Diosynth Biotechnologies Pharmaceutical CDMO Solution Introduction
11.10.4 Fujifilm Diosynth Biotechnologies Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.10.5 Fujifilm Diosynth Biotechnologies Recent Development
11.11 Societal CDMO
11.11.1 Societal CDMO Company Detail
11.11.2 Societal CDMO Business Overview
11.11.3 Societal CDMO Pharmaceutical CDMO Solution Introduction
11.11.4 Societal CDMO Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.11.5 Societal CDMO Recent Development
11.12 Aenova Group
11.12.1 Aenova Group Company Detail
11.12.2 Aenova Group Business Overview
11.12.3 Aenova Group Pharmaceutical CDMO Solution Introduction
11.12.4 Aenova Group Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.12.5 Aenova Group Recent Development
11.13 Eurofins CDMO
11.13.1 Eurofins CDMO Company Detail
11.13.2 Eurofins CDMO Business Overview
11.13.3 Eurofins CDMO Pharmaceutical CDMO Solution Introduction
11.13.4 Eurofins CDMO Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.13.5 Eurofins CDMO Recent Development
11.14 Piramal Group
11.14.1 Piramal Group Company Detail
11.14.2 Piramal Group Business Overview
11.14.3 Piramal Group Pharmaceutical CDMO Solution Introduction
11.14.4 Piramal Group Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.14.5 Piramal Group Recent Development
11.15 WuXi AppTec Group
11.15.1 WuXi AppTec Group Company Detail
11.15.2 WuXi AppTec Group Business Overview
11.15.3 WuXi AppTec Group Pharmaceutical CDMO Solution Introduction
11.15.4 WuXi AppTec Group Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.15.5 WuXi AppTec Group Recent Development
11.16 Fareva
11.16.1 Fareva Company Detail
11.16.2 Fareva Business Overview
11.16.3 Fareva Pharmaceutical CDMO Solution Introduction
11.16.4 Fareva Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.16.5 Fareva Recent Development
11.17 Strides Pharma Science
11.17.1 Strides Pharma Science Company Detail
11.17.2 Strides Pharma Science Business Overview
11.17.3 Strides Pharma Science Pharmaceutical CDMO Solution Introduction
11.17.4 Strides Pharma Science Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.17.5 Strides Pharma Science Recent Development
11.18 Famar Health Care Service
11.18.1 Famar Health Care Service Company Detail
11.18.2 Famar Health Care Service Business Overview
11.18.3 Famar Health Care Service Pharmaceutical CDMO Solution Introduction
11.18.4 Famar Health Care Service Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.18.5 Famar Health Care Service Recent Development
11.19 WuXi Biologics
11.19.1 WuXi Biologics Company Detail
11.19.2 WuXi Biologics Business Overview
11.19.3 WuXi Biologics Pharmaceutical CDMO Solution Introduction
11.19.4 WuXi Biologics Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.19.5 WuXi Biologics Recent Development
11.20 Asymchem
11.20.1 Asymchem Company Detail
11.20.2 Asymchem Business Overview
11.20.3 Asymchem Pharmaceutical CDMO Solution Introduction
11.20.4 Asymchem Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.20.5 Asymchem Recent Development
11.21 Pfizer CentreOne
11.21.1 Pfizer CentreOne Company Detail
11.21.2 Pfizer CentreOne Business Overview
11.21.3 Pfizer CentreOne Pharmaceutical CDMO Solution Introduction
11.21.4 Pfizer CentreOne Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.21.5 Pfizer CentreOne Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Pharmaceutical CDMO Solution Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Active Pharmaceutical Ingredient (API) Manufacturing
Table 3. Key Players of Finished Dosage Formulation (FDF) Development and Manufacturing
Table 4. Key Players of Secondary Packaging
Table 5. Key Players of Others
Table 6. Global Pharmaceutical CDMO Solution Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Pharmaceutical CDMO Solution Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Pharmaceutical CDMO Solution Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Pharmaceutical CDMO Solution Market Share by Region (2018-2023)
Table 10. Global Pharmaceutical CDMO Solution Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Pharmaceutical CDMO Solution Market Share by Region (2024-2033)
Table 12. Pharmaceutical CDMO Solution Market Trends
Table 13. Pharmaceutical CDMO Solution Market Drivers
Table 14. Pharmaceutical CDMO Solution Market Challenges
Table 15. Pharmaceutical CDMO Solution Market Restraints
Table 16. Global Pharmaceutical CDMO Solution Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Pharmaceutical CDMO Solution Market Share by Players (2018-2023)
Table 18. Global Top Pharmaceutical CDMO Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CDMO Solution as of 2022)
Table 19. Ranking of Global Top Pharmaceutical CDMO Solution Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Pharmaceutical CDMO Solution Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Pharmaceutical CDMO Solution Product Solution and Service
Table 23. Date of Enter into Pharmaceutical CDMO Solution Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pharmaceutical CDMO Solution Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Pharmaceutical CDMO Solution Revenue Market Share by Type (2018-2023)
Table 27. Global Pharmaceutical CDMO Solution Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Pharmaceutical CDMO Solution Revenue Market Share by Type (2024-2033)
Table 29. Global Pharmaceutical CDMO Solution Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Pharmaceutical CDMO Solution Revenue Market Share by Application (2018-2023)
Table 31. Global Pharmaceutical CDMO Solution Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Pharmaceutical CDMO Solution Revenue Market Share by Application (2024-2033)
Table 33. North America Pharmaceutical CDMO Solution Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Pharmaceutical CDMO Solution Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Pharmaceutical CDMO Solution Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Pharmaceutical CDMO Solution Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Pharmaceutical CDMO Solution Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Pharmaceutical CDMO Solution Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Pharmaceutical CDMO Solution Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Pharmaceutical CDMO Solution Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Pharmaceutical CDMO Solution Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Pharmaceutical CDMO Solution Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Pharmaceutical CDMO Solution Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Pharmaceutical CDMO Solution Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Pharmaceutical CDMO Solution Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Pharmaceutical CDMO Solution Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Pharmaceutical CDMO Solution Market Size by Country (2024-2033) & (US$ Million)
Table 48. Recipharm AB Company Detail
Table 49. Recipharm AB Business Overview
Table 50. Recipharm AB Pharmaceutical CDMO Solution Product
Table 51. Recipharm AB Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 52. Recipharm AB Recent Development
Table 53. Lonza Group Company Detail
Table 54. Lonza Group Business Overview
Table 55. Lonza Group Pharmaceutical CDMO Solution Product
Table 56. Lonza Group Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 57. Lonza Group Recent Development
Table 58. Catalent Company Detail
Table 59. Catalent Business Overview
Table 60. Catalent Pharmaceutical CDMO Solution Product
Table 61. Catalent Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 62. Catalent Recent Development
Table 63. Patheon (Thermo Fisher Scientific) Company Detail
Table 64. Patheon (Thermo Fisher Scientific) Business Overview
Table 65. Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Product
Table 66. Patheon (Thermo Fisher Scientific) Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 67. Patheon (Thermo Fisher Scientific) Recent Development
Table 68. Siegfried AG Company Detail
Table 69. Siegfried AG Business Overview
Table 70. Siegfried AG Pharmaceutical CDMO Solution Product
Table 71. Siegfried AG Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 72. Siegfried AG Recent Development
Table 73. SGS Quay Pharmaceuticals Company Detail
Table 74. SGS Quay Pharmaceuticals Business Overview
Table 75. SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Product
Table 76. SGS Quay Pharmaceuticals Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 77. SGS Quay Pharmaceuticals Recent Development
Table 78. Curia Company Detail
Table 79. Curia Business Overview
Table 80. Curia Pharmaceutical CDMO Solution Product
Table 81. Curia Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 82. Curia Recent Development
Table 83. Thermo Fisher Scientific Company Detail
Table 84. Thermo Fisher Scientific Business Overview
Table 85. Thermo Fisher Scientific Pharmaceutical CDMO Solution Product
Table 86. Thermo Fisher Scientific Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 87. Thermo Fisher Scientific Recent Development
Table 88. Samsung Biologics Company Detail
Table 89. Samsung Biologics Business Overview
Table 90. Samsung Biologics Pharmaceutical CDMO Solution Product
Table 91. Samsung Biologics Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 92. Samsung Biologics Recent Development
Table 93. Fujifilm Diosynth Biotechnologies Company Detail
Table 94. Fujifilm Diosynth Biotechnologies Business Overview
Table 95. Fujifilm Diosynth Biotechnologies Pharmaceutical CDMO Solution Product
Table 96. Fujifilm Diosynth Biotechnologies Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 97. Fujifilm Diosynth Biotechnologies Recent Development
Table 98. Societal CDMO Company Detail
Table 99. Societal CDMO Business Overview
Table 100. Societal CDMO Pharmaceutical CDMO Solution Product
Table 101. Societal CDMO Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 102. Societal CDMO Recent Development
Table 103. Aenova Group Company Detail
Table 104. Aenova Group Business Overview
Table 105. Aenova Group Pharmaceutical CDMO Solution Product
Table 106. Aenova Group Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 107. Aenova Group Recent Development
Table 108. Eurofins CDMO Company Detail
Table 109. Eurofins CDMO Business Overview
Table 110. Eurofins CDMO Pharmaceutical CDMO Solution Product
Table 111. Eurofins CDMO Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 112. Eurofins CDMO Recent Development
Table 113. Piramal Group Company Detail
Table 114. Piramal Group Business Overview
Table 115. Piramal Group Pharmaceutical CDMO Solution Product
Table 116. Piramal Group Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 117. Piramal Group Recent Development
Table 118. WuXi AppTec Group Company Detail
Table 119. WuXi AppTec Group Business Overview
Table 120. WuXi AppTec Group Pharmaceutical CDMO Solution Product
Table 121. WuXi AppTec Group Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 122. WuXi AppTec Group Recent Development
Table 123. Fareva Company Detail
Table 124. Fareva Business Overview
Table 125. Fareva Pharmaceutical CDMO Solution Product
Table 126. Fareva Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 127. Fareva Recent Development
Table 128. Strides Pharma Science Company Detail
Table 129. Strides Pharma Science Business Overview
Table 130. Strides Pharma Science Pharmaceutical CDMO Solution Product
Table 131. Strides Pharma Science Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 132. Strides Pharma Science Recent Development
Table 133. Famar Health Care Service Company Detail
Table 134. Famar Health Care Service Business Overview
Table 135. Famar Health Care Service Pharmaceutical CDMO Solution Product
Table 136. Famar Health Care Service Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 137. Famar Health Care Service Recent Development
Table 138. WuXi Biologics Company Detail
Table 139. WuXi Biologics Business Overview
Table 140. WuXi Biologics Pharmaceutical CDMO Solution Product
Table 141. WuXi Biologics Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 142. WuXi Biologics Recent Development
Table 143. Asymchem Company Detail
Table 144. Asymchem Business Overview
Table 145. Asymchem Pharmaceutical CDMO Solution Product
Table 146. Asymchem Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 147. Asymchem Recent Development
Table 148. Pfizer CentreOne Company Detail
Table 149. Pfizer CentreOne Business Overview
Table 150. Pfizer CentreOne Pharmaceutical CDMO Solution Product
Table 151. Pfizer CentreOne Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 152. Pfizer CentreOne Recent Development
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmaceutical CDMO Solution Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Pharmaceutical CDMO Solution Market Share by Type: 2022 VS 2033
Figure 3. Active Pharmaceutical Ingredient (API) Manufacturing Features
Figure 4. Finished Dosage Formulation (FDF) Development and Manufacturing Features
Figure 5. Secondary Packaging Features
Figure 6. Others Features
Figure 7. Global Pharmaceutical CDMO Solution Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Pharmaceutical CDMO Solution Market Share by Application: 2022 VS 2033
Figure 9. Pharmaceutical Company Case Studies
Figure 10. Biotechnology Company Case Studies
Figure 11. Others Case Studies
Figure 12. Pharmaceutical CDMO Solution Report Years Considered
Figure 13. Global Pharmaceutical CDMO Solution Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Pharmaceutical CDMO Solution Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Pharmaceutical CDMO Solution Market Share by Region: 2022 VS 2033
Figure 16. Global Pharmaceutical CDMO Solution Market Share by Players in 2022
Figure 17. Global Top Pharmaceutical CDMO Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CDMO Solution as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Pharmaceutical CDMO Solution Revenue in 2022
Figure 19. North America Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Pharmaceutical CDMO Solution Market Share by Country (2018-2033)
Figure 21. United States Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Pharmaceutical CDMO Solution Market Share by Country (2018-2033)
Figure 25. Germany Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Pharmaceutical CDMO Solution Market Share by Region (2018-2033)
Figure 33. China Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Pharmaceutical CDMO Solution Market Share by Country (2018-2033)
Figure 41. Mexico Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Pharmaceutical CDMO Solution Market Share by Country (2018-2033)
Figure 45. Turkey Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Recipharm AB Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 48. Lonza Group Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 49. Catalent Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 50. Patheon (Thermo Fisher Scientific) Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 51. Siegfried AG Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 52. SGS Quay Pharmaceuticals Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 53. Curia Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 54. Thermo Fisher Scientific Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 55. Samsung Biologics Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 56. Fujifilm Diosynth Biotechnologies Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 57. Societal CDMO Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 58. Aenova Group Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 59. Eurofins CDMO Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 60. Piramal Group Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 61. WuXi AppTec Group Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 62. Fareva Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 63. Strides Pharma Science Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 64. Famar Health Care Service Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 65. WuXi Biologics Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 66. Asymchem Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 67. Pfizer CentreOne Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed